Transfer of ADAM17 deficient CD8+ T cells significantly slowed the tumor growth and improved the survival rate in mice compared to mice that received no T cells or WT T cells (Fig. 3d and supplementary Fig. 4e). This evidence concerns the gene CD8A and neoplasm.